Rotavirus Community Remains Committed To Ensuring Cost-Effectiveness, Accessibility Of Vaccines, PATH Associate Says
News Summary
PATH’s “DefeatDD Blog”: Measuring the Next Mile for Rotavirus Vaccines Laura Edison Kallen, senior scientific communications associate at PATH, discusses takeaways from the 13th International Rotavirus Symposium, writing, “[The symposium attendees] presented evidence and shared experiences to help ensure that rotavirus vaccines remain cost-effective, affordable, and accessible in this changing…